In our study, we examined the expression patterns of selected components of the Notch pathway across five molecular subtypes of breast cancer: luminal A, HER2-negative luminal B, HER2-positive luminal B, non-luminal HER2-positive, TNBC. This evidence concerns the gene ERBB2 and breast cancer.